Publication Details

[PS-42] CGA Position Statement on Appropriate and Effective Regulations for Medical Gases within 21 CFR Parts 201, 205, and 210/211

Properties:

Title CGA Position Statement on Appropriate and Effective Regulations for Medical Gases within 21 CFR Parts 201, 205, and 210/211
Edition 3
Published January, 2018
Status Available to the public
Size 44 pages
Publisher CGA
Special Attributes
Notes
Committee Medical Gases


Abstract:

This position statement reflects the Compressed Gas Association’s (CGA) consensus position for how the FDA’s regulations for finished pharmaceuticals found in Title 21 of the U.S. Code of Federal Regulations (21 CFR) Parts 201 (labeling), 205 (wholesale distribution), and 210 and 211 (GMPs), should be revised for designated medical gases or combinations thereof. This position is consistent with established and long standing industry practice yielding safe and efficacious designated medical gases and consistent with the Congressional intent in the FDASIA identifying the need for revisions to 21 CFR.


Cataloging:

Access Publication:

You may be entitled to free or discounted publications. Please login or register before shopping
To download and read this publication, you must have the following software installed:
 
Purchase E-Pub
Purchase Hard Copy
Member Price: $63
Subscriber Price: $63
Non-Member Price: $115
 
Member E-Pub Price: $0
Subscriber E-Pub Price: $0
Non-Member E-Pub Price: $115